Skip to content

The observational study examining the relationship between climate and the onset of migraine in Japan

The observational study examining the relationship between climate and the onset of migraine in Japan - Weather study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000048688
Enrollment
215319
Registered
2022-09-01
Start date
2022-06-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine

Interventions

None listed

Sponsors

Otsuka Pharmaceutical Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - Patients who have been diagnosed with headache based on the following International Classification of Diseases (ICD)-10 codes at least once during the enrollment period ICD10; G43, G440*, G441*, G442*, G443*, G444*, G448* * Headaches other than migraine G43 will also be extracted.

Exclusion criteria

Exclusion criteria: Patients <18 years of age Patients prescribed a total of 120 tablets of triptans per year Patients prescribed a total of 120 tablets of ergotamine per year Patients with comorbidities that may cause secondary headaches

Design outcomes

Primary

MeasureTime frame
[Cross-sectional research study: Case crossover design] -The amount of triptans prescribed in each season [Historical cohort research study] -Date of the first triptan prescription from the index date in the target season

Secondary

MeasureTime frame
[Descriptive research study] - The amount of triptans prescribed per year and month stratified by region - Number of patient visits to the medical institution per year and month

Countries

Japan

Contacts

Public ContactKentaro Yamato

Otsuka Pharmaceuticals Co., Ltd Medical Affairs Department

Yamato.Kentaro@otsuka.jp03-6717-1400

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026